Birzeit Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Talal Kadhim Nasereddin
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 34.8yrs |
CEO ownership | 16.8% |
Management average tenure | no data |
Board average tenure | 21.2yrs |
Recent management updates
Recent updates
CEO
Talal Kadhim Nasereddin (75 yo)
34.8yrs
Tenure
US$35,460
Compensation
Mr. Talal Kadhim Abdellah Nasereddin has been the Chairman of the Board at Birzeit Pharmaceuticals Company since 1990 and also served as it's General Manager since January 4, 1984 until October 31, 2024 an...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board | 34.8yrs | US$35.46k | 16.78% $ 24.3m | |
Director of Marketing Dept. | 21.2yrs | US$35.46k | 6.48% $ 9.4m | |
Director | no data | no data | no data | |
Director | 34.3yrs | US$35.46k | no data | |
Director | 13.6yrs | US$35.46k | no data | |
Director | 32.5yrs | US$35.46k | no data | |
Director | 1.5yrs | no data | no data | |
Director | 1.9yrs | no data | no data |
21.2yrs
Average Tenure
61yo
Average Age
Experienced Board: BPC's board of directors are seasoned and experienced ( 21.2 years average tenure).